evaluating the optimal duration of cpx-351 treatment & best timing for allosct consolidation in aml
Published 6 months ago • 69 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
0:58
management strategies for acute and chronic gvhd following allosct
-
3:44
aml: novel conditioning and maintenance strategies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:48
do all patients require maintenance therapy following allosct?
-
12:05
how to clean/change biobase hematology valves
-
2:45
asset maintenance management (cmms & rtls) | iot for healthcare | borda technology
-
54:06
maintenance management
-
0:45
key trials in cll and designing a concept for treatment
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:42
optimizing maintenance therapy in multiple myeloma: an analysis from the preamble registry
-
1:05
reprogramming leukemia cells into apcs as a novel therapeutic strategy for b-all
-
2:41
an overview of the latest advances in hematology
-
1:23
developing a pro collection tool for patients with scd: key themes which are important to patients
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
1:02
maintenance therapy following treatment for amyloidosis
-
8:13
treatment strategies for high-risk mm
-
5:00
post-transplant maintenance strategies in aml
-
2:03
maintenance therapy in aml
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
3:07
how age as a prognostic factor affects treatment options for all
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials